Document Detail


Evaluation of limited and unlimited food intake during withdrawal in triazolam-dependent baboons.
MedLine Citation:
PMID:  10780809     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Chronic administration of benzodiazepine (BZ) agonists in baboons typically increases food intake, in a dose-dependent manner, during drug administration and suppresses food intake after termination of drug dosing. To determine if suppressed food intake after termination of chronic BZ administration (i.e. withdrawal) was related to increased food consumption during drug administration, the effects of chronic triazolam (1.0 mg/kg/day, intragastrically, for 30-34 days) and subsequent triazolam withdrawal on food intake was studied under two conditions in each of four baboons: (1) when the number of pellets was unlimited; and (2) when the number of pellets was limited so that pellet intake could not increase above the mean number of pellets per day obtained during a preceding vehicle condition. Pellets were available during daily 20-h sessions under a fixed-ratio 10 schedule of reinforcement. All baboons completed both pellet conditions, and the order of exposure was counterbalanced across subjects. During the unlimited pellet condition, pellets per day were increased during triazolam administration and then were suppressed in a time-limited manner when triazolam was discontinued in all four baboons. When pellet intake was limited during triazolam administration, pellet intake after triazolam discontinuation was suppressed in three of four baboons, and the magnitude and duration of suppression was generally less than during the unlimited pellet condition. Other behavioral signs of withdrawal (e.g., tremor/jerk, vomit/retch) were observed in all four baboons under both pellet conditions. These data suggest that the hyperphagic effects of triazolam appear to contribute to the subsequent suppression of food intake during triazolam withdrawal. However, these hyperphagic effects do not account for the entire phenomenon of suppressed food intake during BZ withdrawal.
Authors:
E M Weerts; R R Griffiths
Related Documents :
121159 - Some structure-activity relationships of iodophorous iodine complex compounds. part ii....
1173289 - Effect of oxethazaine hcl on control of food and water intake in the rat.
19031009 - Tetrahydrobiopterin in intestinal lumen: its absorption and secretion in the small inte...
8214279 - Morphologic effects of artemisinin in plasmodium falciparum.
15090899 - Prevention of food-drug interactions with special emphasis on older adults.
10867059 - Free radicals in licorice-flavored sweets can be detected noninvasively using low frequ...
24454949 - Fasting for 24 hours heightens reward from food and food-related cues.
17673989 - Analysis of heat-induced contaminants (acrylamide, chloropropanols and furan) in carboh...
12358039 - International cooperation on harmonisation of technical requirements for approval of ve...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Behavioural pharmacology     Volume:  10     ISSN:  0955-8810     ISO Abbreviation:  Behav Pharmacol     Publication Date:  1999 Jul 
Date Detail:
Created Date:  2000-05-24     Completed Date:  2000-05-24     Revised Date:  2009-07-07    
Medline Journal Info:
Nlm Unique ID:  9013016     Medline TA:  Behav Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  415-21     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA. eweerts@welchlink.welch.jhu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Conditioning, Operant / drug effects
Eating / drug effects*
Hypnotics and Sedatives / adverse effects*
Male
Papio
Reinforcement Schedule
Substance Withdrawal Syndrome / psychology*
Triazolam / adverse effects*
Grant Support
ID/Acronym/Agency:
R01 DA 01147/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Hypnotics and Sedatives; 28911-01-5/Triazolam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Naltrexone does not attenuate the acute behavioral effects of ethanol or pentobarbital in humans.
Next Document:  Spatial learning deficit after NMDA receptor blockade and state-dependency.